IPL_RF_MGX for Meibomian Gland Dysfunction
Phase-Based Progress Estimates
Effectiveness
Safety
Manhattan Face and Eye clinic, New York, NY
Meibomian Gland Dysfunction+4 More
IPL_RF_MGX - DeviceEligibility
18+
All Sexes
What conditions do you have?
Select
Eligibility
18+
All Sexes
What conditions do you have?
Select
Study Summary
The purpose of this single-arm pilot study is to evaluate the feasibility and safety of combination therapy of intense pulsed light (IPL) and (Radiofrequency) RF for treatment of Dry eye disease (DED) due to Meibomian gland dysfunction (MGD).
Eligible Conditions
- Meibomian Gland Dysfunction
- Dry Eye Syndromes
Treatment Effectiveness
Effectiveness Progress
Other trials for Meibomian Gland Dysfunction
Study Objectives
1 Primary · 5 Secondary · Reporting Duration: 4 weeks after the 4th treatment session
Week 4
Eyelid appearance
MMP-9 test
Meibography
NIBUT
Number of expressible glands
OSDI
Predominant quality of the meibum
modified meibomian gland score (mMGS)
Trial Safety
Safety Progress
Other trials for Meibomian Gland Dysfunction
Trial Design
1 Treatment Group
Study arm
1 of 1
Experimental Treatment
30 Total Participants · 1 Treatment Group
Primary Treatment: IPL_RF_MGX · No Placebo Group · N/A
Study arm
Device
Experimental Group · 1 Intervention: IPL_RF_MGX · Intervention Types: DeviceTrial Logistics
Trial Timeline
Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 4 weeks after the 4th treatment session
Closest Location: Manhattan Face and Eye clinic · New York, NY
N/AFirst Recorded Clinical Trial
1 TrialsResearching Meibomian Gland Dysfunction
0 CompletedClinical Trials
Who is running the clinical trial?
Lumenis Ltd.Lead Sponsor
23 Previous Clinical Trials
641 Total Patients Enrolled
4 Trials studying Meibomian Gland Dysfunction
176 Patients Enrolled for Meibomian Gland Dysfunction
Lumenis Be Ltd.Lead Sponsor
27 Previous Clinical Trials
701 Total Patients Enrolled
4 Trials studying Meibomian Gland Dysfunction
176 Patients Enrolled for Meibomian Gland Dysfunction
James Chelnis, MDPrincipal InvestigatorManhattan Face and Eye
2 Previous Clinical Trials
2,000 Total Patients Enrolled
Chantel Garcia, ODPrincipal InvestigatorCarolina Eye Doctors
Eligibility Criteria
Age 18+ · All Participants · 7 Total Inclusion Criteria
Mark “yes” if the following statements are true for you:You have moderate to severe dry eye.
You have skin type I-IV.
About The Reviewer
Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.
Popular Clinical Trials
Top Clinical Trials in Cities
Relevant Clinical Trials
Unbiased Results
We believe in providing patients with all the options.Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.Back to top
Conditions
Cancer Related
Treatments